Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
Processa Pharmaceuticals Inc (NASDAQ: PCSA) closed the day trading at $3.78 down -3.08% from the previous closing price of $3.9. In other words, the price has decreased by -$3.08 from its previous closing price. On the day, 0.57 million shares were traded. PCSA stock price reached its highest trading level at $3.9914 during the session, while it also had its lowest trading level at $3.42.
Ratios:
For a better understanding of PCSA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.76 and its Current Ratio is at 3.76. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, H.C. Wainwright on April 25, 2024, initiated with a Buy rating and assigned the stock a target price of $8.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 27 ’25 when Yorke Justin W bought 12,400 shares for $0.80 per share. The transaction valued at 9,889 led to the insider holds 12,400 shares of the business.
Ng George K bought 87,200 shares of PCSA for $69,542 on Jan 27 ’25. The Chief Executive Officer now owns 87,200 shares after completing the transaction at $0.80 per share. On Jan 27 ’25, another insider, Young David, who serves as the Pres. Research & Development of the company, bought 124,500 shares for $0.80 each. As a result, the insider paid 99,289 and bolstered with 205,405 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PCSA now has a Market Capitalization of 8564603 and an Enterprise Value of 2256186.
Stock Price History:
The Beta on a monthly basis for PCSA is 1.14, which has changed by -0.81935483 over the last 52 weeks, in comparison to a change of 0.14402747 over the same period for the S&P500. Over the past 52 weeks, PCSA has reached a high of $27.00, while it has fallen to a 52-week low of $2.74. The 50-Day Moving Average of the stock is -48.95%, while the 200-Day Moving Average is calculated to be -44.30%.
Shares Statistics:
Over the past 3-months, PCSA traded about 1.05M shares per day on average, while over the past 10 days, PCSA traded about 4403684 shares per day. A total of 2.11M shares are outstanding, with a floating share count of 2.00M. Shares short for PCSA as of 1764288000 were 217365 with a Short Ratio of 5.16, compared to 1761868800 on 361981. Therefore, it implies a Short% of Shares Outstanding of 217365 and a Short% of Float of 9.6999995.
Earnings Estimates
The dynamic stock of Processa Pharmaceuticals Inc (PCSA) is currently being evaluated by a team of 1.0 analysts, each contributing to its current rating.
Analysts are recommending an EPS of between -$10.75 and -$10.75 for the fiscal current year, implying an average EPS of -$10.75. EPS for the following year is -$3.75, with 1.0 analysts recommending between -$3.75 and -$3.75.
